Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Granules India Buyback – Ray Of Hope During Coronavirus Turmoil?

Q4 Impacted By Export Restrictions

Mar 17 2020

• By Vibha Ravi

Pandemic — Will Granules Prove To Be A Good Bet? • Source: Shutterstock

Related Content

Granules India Next On PE Buy List?

Dec 02 2019

Additional Topics

India Asia Pacific Commercial Coronavirus COVID-19 Business Strategies BioPharmaceutical

More from Business

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.